Clinical trial

Dalfampridine in Egyptian Patients With Multiple Sclerosis

NCT05730738

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-06-01

PhaseNA

Study timeline

Study start (actual)2021-06-01Date precision: day

Registry last updated2023-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Dalfampridine ER, 10 Mg Oral Tablet, Extended ReleaseDRUG

PlaceboDRUG

Sponsors & collaborators

Ain Shams Universitylead sponsor

Mapped research locations

CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05730738 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.